Edmond de Rothschild Holding’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-4,100
| Closed | -$151K | – | 629 |
|
|
2026
Q1 | $151K | Sell |
4,100
-125
| -3% | -$5.92K | ﹤0.01% | 390 |
|
|
2025
Q4 | $215K | Buy |
+4,225
| New | +$216K | ﹤0.01% | 377 |
|
|
2025
Q2 | – | Sell |
-200
| Closed | -$13.9K | – | 585 |
|
|
2025
Q1 | $13.9K | Hold |
200
| – | – | ﹤0.01% | 525 |
|
|
2024
Q4 | $17.2K | Hold |
200
| – | – | ﹤0.01% | 551 |
|
|
2024
Q3 | $23.8K | Sell |
200
-425
| -68% | -$56.7K | ﹤0.01% | 571 |
|
|
2024
Q2 | $89.2K | Hold |
625
| – | – | ﹤0.01% | 509 |
|
|
2024
Q1 | $80.3K | Buy |
+625
| New | +$74.4K | ﹤0.01% | 538 |
|
|
2022
Q4 | – | Sell |
-3,266
| Closed | -$163K | – | 813 |
|
|
2022
Q3 | $163K | Hold |
3,266
| – | – | ﹤0.01% | 499 |
|
|
2022
Q2 | $182K | Hold |
3,266
| – | – | ﹤0.01% | 495 |
|
|
2022
Q1 | $181K | Hold |
3,266
| – | – | ﹤0.01% | 511 |
|
|
2021
Q4 | $183K | Sell |
3,266
-490
| -13% | -$26.5K | ﹤0.01% | 546 |
|
|
2021
Q3 | $180K | Hold |
3,756
| – | – | ﹤0.01% | 555 |
|
|
2021
Q2 | $157K | Sell |
3,756
-1,344
| -26% | -$52.1K | ﹤0.01% | 564 |
|
|
2021
Q1 | $172K | Sell |
5,100
-750
| -13% | -$26.7K | ﹤0.01% | 493 |
|
|
2020
Q4 | $204K | Sell |
5,850
-850
| -13% | -$29.4K | 0.01% | 435 |
|
|
2020
Q3 | $233K | Sell |
6,700
-264
| -4% | -$8.8K | 0.01% | 385 |
|
|
2020
Q2 | $228K | Sell |
6,964
-20,000
| -74% | -$638K | 0.01% | 359 |
|
|
2020
Q1 | $812K | Sell |
26,964
-714
| -3% | -$21.3K | 0.04% | 228 |
|
|
2019
Q4 | $801K | Hold |
27,678
| – | – | 0.03% | 260 |
|
|
2019
Q3 | $715K | Buy |
27,678
+1,314
| +5% | +$33.2K | 0.03% | 279 |
|
|
2019
Q2 | $672K | Sell |
26,364
-400
| -1% | -$9.89K | 0.03% | 271 |
|
|
2019
Q1 | $700K | Sell |
26,764
-640
| -2% | -$15.7K | 0.02% | 263 |
|
|
2018
Q4 | $632K | Buy |
27,404
+648
| +2% | +$14.4K | 0.02% | 287 |
|
|
2018
Q3 | $630K | Sell |
26,756
-2,600
| -9% | -$63.5K | 0.02% | 318 |
|
|
2018
Q2 | $677K | Buy |
29,356
+4,800
| +20% | +$114K | 0.02% | 312 |
|
|
2018
Q1 | $604K | Sell |
24,556
-5,400
| -18% | -$142K | 0.02% | 331 |
|
|
2017
Q4 | $804K | Buy |
29,956
+3,374
| +13% | +$85.8K | 0.02% | 291 |
|
|
2017
Q3 | $640K | Sell |
26,582
-4,880
| -16% | -$110K | 0.02% | 335 |
|
|
2017
Q2 | $675K | Sell |
31,462
-7,062
| -18% | -$143K | 0.02% | 332 |
|
|
2017
Q1 | $660K | Sell |
38,524
-9,720
| -20% | -$169K | 0.02% | 337 |
|
|
2016
Q4 | $865K | Sell |
48,244
-72,038
| -60% | -$1.31M | 0.02% | 295 |
|
|
2016
Q3 | $2.5M | Buy |
120,282
+90,082
| +298% | +$2.23M | 0.08% | 178 |
|
|
2016
Q2 | $812K | Hold |
30,200
| – | – | 0.03% | 283 |
|
|
2016
Q1 | $818K | Buy |
30,200
+1,800
| +6% | +$48.2K | 0.03% | 289 |
|
|
2015
Q4 | $825K | Buy |
28,400
+12,800
| +82% | +$354K | 0.02% | 300 |
|
|
2015
Q3 | $423K | Buy |
15,600
+14,600
| +1,460% | +$413K | 0.01% | 369 |
|
|
2015
Q2 | $27K | Buy |
+1,000
| New | +$28.1K | ﹤0.01% | 703 |
|
Other funds holding NVO
F
Edmond de Rothschild Holding's NVO Position: Q2 2026 in Review
Edmond de Rothschild Holding sold out of Novo Nordisk (NVO) in Q2 2026, closing a stake of 4,100 shares — an estimated $151K sold.
Edmond de Rothschild Holding first reported a position in NVO in Q2 2015 and held it in 37 quarters. The position peaked at $2.5M in Q3 2016. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Edmond de Rothschild Holding reported no remaining Novo Nordisk position as of Q2 2026 after selling out during the quarter.
- Edmond de Rothschild Holding sold 4,100 Novo Nordisk shares in Q2 2026, an estimated $151K.
- Edmond de Rothschild Holding first reported a position in Novo Nordisk in Q2 2015 and held it in 37 quarters.
- Edmond de Rothschild Holding's Novo Nordisk position peaked at $2.5M in Q3 2016.
- 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Edmond de Rothschild Holding's 13F filing for Q2 2026, filed 10 Aug 2026.